Impact of Drug-Eluting Stents on Clinical and Angiographic Outcomes in Dialysis Patients

Abstract

In this retrospective study, SES, in comparison with BMS, reduced in-stent restenosis in patients on dialysis. However, in-segment restenosis and TLR were not statistically different between lesions treated with SES and those with BMS.